Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Movement Disorders

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.1069PMID 11295770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Subthalamic Nucleus and Tremor in Parkinson's Disease

  2008cited by this paper
• Irreversible motor impairment in young addicts – ephedrone, manganism or both?

  2007cited by this paper
• What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

  2001influential reference
• Multiple system atrophy

  2001cited by this paper
• Acute Challenge with Apomorphine and Levodopa in Parkinsonism

  2000cited by this paper
• Apomorphine test in the assessment of parkinsonian patients: a meta-analysis.

  1999cited by this paper
• Pharmacodynamics of the long-duration response to levodopa in PD

  1999cited by this paper
• Reduction of parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single‐dose challenges

  1999cited by this paper
• Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD)

  1999cited by this paper
• Consensus statement on the diagnosis of multiple system atrophy

  1998cited by this paper
• Levodopa therapy

  1998cited by this paper
• Stepwise Intravenous Infusion of Apomorphine to Determine the Therapeutic Window in Patients with Parkinson's Disease

  1998cited by this paper
• Short‐term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease

  1997cited by this paper
• Long‐duration response to levodopa influences the pharmacodynamics of short‐duration response in Parkinson's disease

  1997cited by this paper
• Effects of supra-threshold levodopa doses on dyskinesias in advanced Parkinson's disease

  1997cited by this paper
• Levodopa ethylester : A novel rescue therapy for response fluctuations in parkinson's disease

  1996cited by this paper
• Neurobiology of L-DOPAergic systems.

  1996cited by this paper
• The subacute levodopa test for evaluating long‐duration response in parkinson's disease

  1995cited by this paper
• Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease

  1995cited by this paper
• Movement disorders 3: Marsden C D, Fahn S Butterworth-Heinemann UK, 1994 ISBN 0 750614 12 9 529pp RRP $110.00

  1995cited by this paper
• Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease.

  1995cited by this paper
• Long-duration response to levodopa

  1995cited by this paper
• Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.

  1994cited by this paper
• Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment

  1994cited by this paper
• Usefulness of movement time in the assessment of Parkinson's disease

  1994cited by this paper
• Clinical usefulness of apomorphine in movement disorders.

  1994cited by this paper
• Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology

  1994cited by this paper
• Dopamine agonists in Parkinson's disease: a look at apomorphine

  1993cited by this paper
• Apomorphine test for dopaminergic responsiveness: A dose assessment study

  1993cited by this paper
• Core assessment program for intracerebral transplantations (CAPIT)

  1992cited by this paper
• Intravenous boluses and continuous infusions of L‐DOPA methyl ester in fluctuating patients with Parkinson's disease

  1992cited by this paper
• Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification

  1992cited by this paper
• Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease.

  1992cited by this paper
• Levodopa‐induced diphasic dyskinesias improved by subcutaneous apomorphine

  1992cited by this paper
• What features improve the accuracy of clinical diagnosis in Parkinson's disease

  1992cited by this paper
• The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease.

  1992cited by this paper
• The dopaminergic response in multiple system atrophy.

  1992cited by this paper
• Challenge tests to predict the dopaminergic response in untreated Parkinson's disease

  1991cited by this paper
• Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects.

  1991cited by this paper
• Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes.

  1990cited by this paper
• Parkinson's Disease and Movement Disorders

  1990cited by this paper
• Levodopa efficacy and pathological basis of Parkinson syndrome.

  1990influential reference
• Apomorphine in the diagnosis and treatment of parkinsonian tremor.

  1990cited by this paper
• Parkinsonism‐plus syndromes

  1989influential reference
• Parkinson's Disease and Movement Disorders

  1988cited by this paper
• Continuous subcutaneous lisuride infusions in Parkinson's disease.

  1988cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Recent Developments in Parkinson's Disease

  1986cited by this paper
• Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.

  1975cited by this paper

• Machine learning models for the prediction of levodopa response to tremor in Parkinson’s disease

  2026cites this paper
• Consensus on the clinical application of the acute levodopa challenge test in Parkinson's disease (2025).

  2026cites this paper
• A Network Centered on the Visual‐Motor Cortex Is Critically Involved in Postural Abnormality in Parkinson's Disease

  2025cites this paper
• Technical Feasibility of Quantitative Susceptibility Mapping Radiomics for Predicting Deep Brain Stimulation Outcomes in Parkinson Disease.

  2025cites this paper
• Neuropsychiatric fluctuations in Parkinson's disease: A French multicenter study of the NFS psychometric properties.

  2025cites this paper
• Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease

  2025cites this paper
• Eye movement parameters as biomarkers for diagnosis and levodopa responsiveness in patients with Parkinson’s disease

  2025cites this paper
• Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis

  2025cites this paper
• Data‐Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness

  2025cites this paper
• Effects of oral levodopa on motor symptoms and gait impairments in Parkinson’s disease: a systematic review and meta-analysis

  2025influential citation
• Improvement by Medication Less than Expected in Parkinson's Disease: Blinded Evaluation of Levodopa Response

  2024cites this paper
• Kinect-based objective assessment of the acute levodopa challenge test in parkinsonism: a feasibility study

  2024cites this paper
• Instrumented timed up and go test and machine learning-based levodopa response evaluation: a pilot study

  2024influential citation
• Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients

  2024cites this paper
• Machine‐learning model for the prediction of acute orthostatic hypotension after levodopa administration

  2024cites this paper
• Brain network centrality and connectivity are associated with clinical subtypes and disease progression in Parkinson’s disease

  2024cites this paper
• Parkinson's Disease Tremor Differentially Responds to Levodopa and Subthalamic Stimulation

  2023cites this paper
• Fundamentals of deep brain stimulation for Parkinson's disease in clinical practice: part 1

  2023cites this paper
• Acute effect of levodopa on orthostatic hypotension and its association with motor responsiveness in Parkinson's disease: Results of acute levodopa challenge test.

  2023cites this paper
• Diagnostic pitfalls in young onset parkinsonism and its unique challenges: A case report from rural Nepal

  2023cites this paper
• Fluctuations in Parkinson’s disease and personalized medicine: bridging the gap with the neuropsychiatric fluctuation scale

  2023cites this paper
• Integrative Brain States Facilitate the Expression of Parkinson's Tremor

  2023cites this paper
• Apomorphine subcutaneous titration in Parkinson’s disease - the effectiveness and safety of apomorphine challenges: A Literature Review

  2023cites this paper
• Pruebas diagnósticas para la enfermedad de Parkinson

  2023cites this paper
• Machine Learning in Tremor Analysis: Critique and Directions

  2023cites this paper
• Age as a risk factor for orthostatic hypotension induced by the levodopa challenge test in patients with Parkinson’s disease: Results from a single-center trial

  2023cites this paper
• Long‐Duration Response to Levodopa, Motor Learning, and Neuroplasticity in Early Parkinson's Disease

  2023cites this paper
• Effect of physical therapy on the isokinetic performance of knee flexors and extensors and functional balance in older adults with Parkinson's disease, according to severity.

  2023cites this paper
• The altered spontaneous neural activity in patients with Parkinson's disease and its predictive value for the motor improvement of deep brain stimulation

  2023cites this paper
• Levodopa responsiveness and white matter alterations in Parkinson's disease: A DTI‐based study and brain network analysis: A cross‐sectional study

  2022influential citation
• Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study

  2022cites this paper
• Association Between Microbial Tyrosine Decarboxylase Gene and Levodopa Responsiveness in Patients With Parkinson Disease

  2022influential citation
• Normalization effect of levodopa on hierarchical brain function in 1 Parkinson ’ s disease 2 Short title : Levodopa-induced brain normalization of PD 3

  2022cites this paper
• Normalization effect of levodopa on hierarchical brain function in Parkinson’s disease

  2022cites this paper
• Diagnosis and Pharmacological Management of Parkinson’s Disease: A Review

  2022cites this paper
• Automatic Resting Tremor Assessment in Parkinson’s Disease Using Smartwatches and Multitask Convolutional Neural Networks

  2021cites this paper
• Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort

  2021cites this paper
• The amplitude of low-frequency fluctuation predicts levodopa treatment response in patients with Parkinson's disease.

  2021cites this paper
• Up-To-Date Practice of Deep Brain Stimulation for Parkinson's Disease

  2021cites this paper
• Discrimination of idiopathic Parkinson's disease and vascular parkinsonism based on gait time series and the levodopa effect.

  2021cites this paper
• Levodopa responsiveness in Parkinson’s disease patients and white matter alterations in diffusion tensor imaging: a cross-sectional tract-based spatial statistics study

  2021cites this paper
• Functional Connectomics and Disease Progression in Drug‐Naïve Parkinson's Disease Patients

  2021cites this paper
• Levodopa challenge test: indications, protocol, and guide

  2020cites this paper
• Pharmacological management of Parkinson’s disease in older people

  2020cites this paper
• Safinamide as an adjunct therapy in older patients with Parkinson’s disease: a retrospective study

  2020cites this paper
• Base-peak assessment of levodopa response and detection of fluctuating patients in Parkinson’s disease

  2020cites this paper
• Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease

  2020cites this paper
• Design and Operation of the Lombardy Parkinson's Disease Network

  2020cites this paper
• Apomorphine in Parkinson's Disease—The Questions Raised

  2020cites this paper
• High levodopa plasma concentration after oral administration predicts levodopa-induced dyskinesia in Parkinson's disease.

  2020cites this paper
• Assessing the effect of current steering on the total electrical energy delivered and ambulation in Parkinson’s disease

  2020cites this paper
• Cognitive load amplifies Parkinson's tremor through excitatory network influences onto the thalamus.

  2020cites this paper
• Measurement of Step Angle for Quantifying the Gait Impairment of Parkinson’s Disease by Wearable Sensors: Controlled Study

  2020cites this paper
• Terapias de infusión en la enfermedad de Parkinson avanzada

  2019cites this paper
• Medication status and dual-tasking on turning strategies in Parkinson disease.

  2019cites this paper
• Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism.

  2019cites this paper
• Parkinson Disease-Related Pattern of Glucose Metabolism Associated With the Potential for Motor Improvement After Deep Brain Stimulation.

  2019cites this paper
• Quantitative Assessment of Finger Movement Profile in a Visual-Motor Task Based on a Tablet Computer: The Application in Parkinson’s Disease

  2019cites this paper
• Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson's tremor.

  2019influential citation
• The Parkinson's Disease Composite Scale Is Adequately Responsive to Acute Levodopa Challenge

  2019influential citation
• Prediction of the Levodopa Challenge Test in Parkinson’s Disease Using Data from a Wrist-Worn Sensor

  2019cites this paper
• How to approach a patient with parkinsonism - red flags for atypical parkinsonism.

  2019cites this paper
• Pruebas Terapéuticas Con Fines Diagnósticos En Trastornos Del Movimiento

  2019cites this paper
• Measurement of Step Angle for Quantifying the Gait Impairment of Parkinson’s Disease by Wearable Sensors: Controlled Study (Preprint)

  2019cites this paper
• Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: a pilot study

  2018cites this paper
• The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study

  2018cites this paper
• The nature of postural tremor in Parkinson disease

  2018cites this paper
• Investigating the Practical and Clinical Effectiveness of Applying Current Steering to Deep Brain Stimulation for Parkinsonian Gait Therapy

  2018cites this paper
• Levodopa Effect and Motor Function in Late Stage Parkinson’s Disease

  2018cites this paper
• Side effects induced by the acute levodopa challenge in Parkinson’s Disease and atypical parkinsonisms

  2017cites this paper
• Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort

  2017cites this paper
• The patient's perspective: The effect of levodopa on Parkinson symptoms.

  2017cites this paper
• Investigating The Acute Levodopa Response In Early To Advanced Parkinson’s Disease

  2017cites this paper
• Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson’s disease

  2017cites this paper
• Cognitive Stress Reduces the Effect of Levodopa on Parkinson's Resting Tremor

  2017cites this paper
• Subjective Perceived Motor Improvement after Acute Levodopa Challenge in Parkinson’s Disease

  2016cites this paper
• Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus

  2016cites this paper
• Facial tremors in patients with and without parkinsonism

  2016cites this paper
• Ultrasound Strain Elastography in Assessment of Muscle Stiffness in Acute Levodopa Challenge Test: A Feasibility Study.

  2016cites this paper
• Deep Brain Stimulation in a Dopaminergic Non-responsive Patient With Parkinson's Disease: Case Report and Systematic Review.

  2015influential citation
• Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome

  2015cites this paper
• Effective Delivery of Apomorphine in the Management of Parkinson Disease: Practical Considerations for Clinicians and Parkinson Nurses

  2015cites this paper
• Multiple System Atrophy

  2014cites this paper
• Asymmetric Postural Tremor Preceding DOPA-Responsive Parkinsonism – the Transition Disease

  2014cites this paper
• POLG1-related levodopa-responsive parkinsonism.

  2014cites this paper
• Recurrent and fatal akinetic crisis in genetic‐mitochondrial parkinsonisms

  2014cites this paper
• Evaluation of the Objective Posturo-Locomotor-Manual Method in Patients with Parkinsonian Syndromes

  2013cites this paper
• Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.

  2013cites this paper
• Parkinson's disease and motor function - a validation of the PLM method

  2013cites this paper
• EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease

  2013cites this paper
• Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies

  2013cites this paper
• Single Photon Emission Computed Tomography Striatal Asymmetry Index May Predict Dopaminergic Responsiveness in Parkinson Disease

  2011cites this paper
• Comparison of the efficacy of unipolar and bipolar electrode configuration during subthalamic deep brain stimulation.

  2011cites this paper
• Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies

  2010cites this paper
• Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward

  2010cites this paper
• INPH and Parkinson disease: differentiation by levodopa response

  2010cites this paper
• Biomarkers of Alzheimer's and Parkinson's Disease

  2010cites this paper
• Multiple System Atrophy: Clinical Features and Management

  2010cites this paper
• Acute stepwise challenge test with levodopa in treated patients with parkinsonism.

  2009cites this paper
• Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease.

  2008cites this paper